ST Nanwei (603880.SH) announced first-quarter results, net profit of 1.75 million yuan, a year-on-year decrease of 74.82%

ST Nanwei (603880.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 1.3 during the reporting period...

Zhitong FinanceApr 29 13:43 ET

ST Nanwei (603880.SH) announced 2023 annual results with a net loss of 147 million yuan

According to the Zhitong Finance App, ST Nanwei (603880.SH) disclosed the 2023 annual report. The company achieved revenue of 600 million yuan in 2023, an increase of 10.03%; net profit loss to mother was 147 million yuan, an increase over the previous year; loss after deducting non-net profit of 147 million yuan, a year-on-year increase; and basic earnings per share were -0.51 yuan. During the reporting period, the company's main business revenue increased slightly compared to last year; the decrease in net profit attributable to the parent company was mainly due to an oversupply of protective equipment, and price competition was intense; credit impairment losses and asset impairment losses increased.

Zhitong FinanceMar 29 07:57 ET

ST Nanwei (603880.SH): There is no business involved in the AI medical field yet

Gelonghui, March 19丨ST Nanwei (603880.SH) said on the investor interactive platform that the company has no business involved in the AI medical field yet.

Gelonghui FinanceMar 19 03:46 ET

ST Nanwei (603880.SH): Shareholder Xu Dong has purchased 1.5565 million shares of the company

Gelonghui, Feb. 20 | ST Nanwei (603880.SH) announced that today the company received a notice from Mr. Xu Dong, a shareholder of more than 5%: As of February 20, 2024, Mr. Xu Dong had purchased 1,056,500 shares of the company through self-funded centralized bidding transactions in the secondary market. All proceeds from this share repurchase are owned by the listed company.

Gelonghui FinanceFeb 20 05:22 ET

Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

The Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) share price has fared very poorly over the last month, falling by a substantial 28%. The drop over the last 30 days has capped off a tough year f

Simply Wall StFeb 6 17:07 ET

ST Nanwei (603880.SH): Jiangsu Securities Regulatory Bureau takes corrective regulatory measures against shareholder Xu Dong

ST Nanwei (603880.SH) issued an announcement. Recently, Xu Dong, a shareholder of more than 5% of the company, received the Jiangsu Securities Regulatory Bureau...

Zhitong FinanceDec 17, 2023 17:56 ET